These could be administered at least 4 months after the previous one, with a focus on people who have received a previous booster more than 6 months ago.
Currently authorised vaccines continue to be highly effective in reducing #COVID19 hospitalisations, severe disease & deaths.
As a new wave is currently underway in Europe, with increasing rates of hospital and intensive care unit (ICU) admissions, it is critical that public health authorities now consider people between 60 and 79 as well as vulnerable persons of any age for a second booster.
RT @EU_Health: As we've seen over the last 2⃣ years, the #COVID19 situation can change very quickly
In April, we urged 🇪🇺 countries to improve preparedness & their readiness to respond, together
This means continued surveillance, testing & sustained vaccination
Weekly #COVID19 country overview report is out now!
Cases rates among people aged 65+ increased in 22 of the 24 countries reporting data correspond to a 32% increase compared to the previous week at EU/EEA level, reaching 62.8% of the pandemic maximum.
#JustPublished!
#Update to our Rapid Risk Assessment on #monkeypox outbreak in the EU/EEA.
Read more about the case count, symptoms, measures to take and learn more about how to communicate about #MPX.
All that in a handy thread below ⬇️⬇️⬇️
RT @ECDC_Outbreaks: #JustPublished!
Rapid Risk Assessment: #Monkeypox multi-country outbreak - first update.
Since early May 2022 and as of 7 July, 26 EU/EEA countries have reported 4 908 cases,…
RT @Eurosurveillanc: @ECDC_EU @ECDC_Outbreaks @rki_de Rapid communication
A shift from travel-associated cases to autochthonous #transmission with Berlin as epicentre of #monkeypox outbreak in 🇩🇪, May─June 2022
👇🏽
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.27.2200499
@RuscherClaudia @BarteltLab @dr_uwetweets @rki_de
RT @WHOUkraine: This week, WHO has carried out a mission to #Ukraine to provide technical support to the Government on cholera preparedness & response activities amidst the war w/@WHOFoundation support.
@HelenBranswell Hello @HelenBranswell!
Just a side note - you can change some of the graphs in the report to show the indicators broken down in different forms. There is also an epicurve based on symptoms onset!
RT @HelenBranswell: 1. Short #MPXV thread, based on data from @WHO_Europe & @ECDC:
The Euro #monkeypox outbreak continues to grow. Of +5200 cases reported here, 29 were women — which seems to be an increase. 15 health workers among cases; not clear if exposure was on the job.
https://monkeypoxreport.ecdc.europa.eu/
RT @EMA_News: #EMA will continue monitoring the monkeypox #outbreak with @ECDC_EU, #HERA @euhealth and developers to help making medicines available for the prevention and treatment of #monkeypox 💊💉. #EMAPresser
RT @EMA_News: #EMA is working closely with @ECDC_EU, @EU_Health, #HERA and national public health authorities to identify the best approaches to vaccination in the 🇪🇺 and to deal with potential new waves of #COVID19 infections. #EMAPresser
RT @EMA_News: We are working towards approval of adapted #COVID19 #vaccines in September. #EMAPresser
RT @EMA_News: We are also in close contact with manufacturers of #vaccines based on different platforms other than mRNA, especially adjuvanted protein vaccines. #EMAPresser
RT @EMA_News: Bivalent #mRNA #vaccines that combine two strains of SARS-CoV-2, one of which is an #Omicron strain, appear to offer an even wider immune response. #EMAPresser
RT @EMA_News: The supplies of Imvanex are currently very limited in the 🇪🇺. While we fast-track the extension of Imvanex, Member States can use imported #vaccine Jynneos from the 🇺🇸 as a temporary measure to vaccinate at-risk groups. #EMAPresser
RT @EMA_News: About #monkeypox: EMA’s human medicines committee #CHMP is now reviewing data to extend the use of the smallpox #vaccine Imvanex for monkeypox. #EMAPresser
RT @Eurosurveillanc: This week’s 𝘌𝘶𝘳𝘰𝘴𝘶𝘳𝘷𝘦𝘪𝘭𝘭𝘢𝘯𝘤𝘦 issue is here. Check it out!
#MonkeypoxVirus #MPX #MPXV #AcuteRespiratoryIllness #ARI #publichealth #surveillance #outbreak
RT @SoniaBoender: Out now @Eurosurveillanc 📰 https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.27.2100865
We used routine emergency department data for syndromic #surveillance of acute respiratory illness, to monitor the trends/timing/duration/magnitude and severity of illness by resp viruses incl #influenza & #SARSCoV2
Unofficial automated mirror. No copyright asserted. ∎ The European Centre for Disease Prevention and Control. We aim to strengthen #Europe's defences against infectious diseases.